IPP Bureau
Panacea to produce 100 mn doses of Sputnik V vaccine
By IPP Bureau - April 06, 2021
Production of Sputnik V at Panacea Biotec sites will help facilitate global supply of Sputnik V to international partners of RDIF
GlaxoSmithKline approves sale of Vemgal plant
By IPP Bureau - April 05, 2021
Hetero is one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs for the treatment of HIV/AIDS
Piramal Enterprises forays into peptide with Hemmo Pharma : ICICI Securities
By IPP Bureau - April 05, 2021
ICICI Securities expects Hemmo to grow its revenue at a CAGR of 30.0% over FY21E-FY23E
Zydus seeks DCGI approval for the use of Pegylated Interferon alpha-2b in treating COVID-19
By IPP Bureau - April 05, 2021
PegIFN in COVID19 has several add-on advantages compared to other anti-viral agents
Tatva Chintan Pharma Chem plans for IPO files DRHP with SEBI
By IPP Bureau - April 05, 2021
TCPCL is the largest and only commercial manufacturer of SDAs for zeolites in India
Reports on GSK Pharmaceuticals by ICICI Securities
By IPP Bureau - April 03, 2021
GSKP announced sale of its newly constructed manufacturing plant at Vemgal, Karnataka to Hetero Labs for a cash consideration of Rs1.8bn
Lonza completes divestment of two sites to NextPharma
By IPP Bureau - April 02, 2021
Strategic divestment of Ploermel and Edinburgh sites will enable NextPharma to benefit from operational synergies and optimize existing expertise and technologies
Piramal Pharma to acquire 100% stake in Hemmo for Rs 775 Cr
By IPP Bureau - April 01, 2021
This acquisition marks PPS’ foray into the development and manufacturing of peptide APIs
Promoters of Lincoln Pharma increases holding by 4.9%
By IPP Bureau - April 01, 2021
The promoter holding in the company has increased to 37.25%, a rise of 4.9% from 32.35% as of 31 March 2020
Our collective decisions will shape the future policy for equitable distribution of vaccine: Dr. Harsh Vardhan
By IPP Bureau - March 31, 2021
India produces 60% of the world’s vaccine
Investment opportunities in India’s healthcare sector: NITI Aayog
By IPP Bureau - March 31, 2021
Report outlines the wide array of investment opportunities in various segments of India’s healthcare sector
Bliss GVS Pharma files suit for IPR infringement
By IPP Bureau - March 30, 2021
The company had filed a suit in the High Court of Justice, Ghana
Need for integration of various regulatory agencies : Pharma secretary
By IPP Bureau - March 26, 2021
Integration of various regulatory agencies with a single-window system and putting in place a transparent, stable, predictable and easy to navigate interface.
COVID-19 drug Remdesivir now priced at Rs. 899
By IPP Bureau - March 25, 2021
Zydus has made its brand of Remdesivir, Remdac more affordable at Rs. 899 for a 100 mg lyophilized injection.
LupinLife to promote hand hygiene at Kumbh Mela 2021
By IPP Bureau - March 24, 2021
Lupin will provide five lakh LupiSafe hand sanitizers to policemen and frontline workers deployed at strategic locations
